Landscapes / Targets
dopamine D1
2 drugs act on dopamine D1, in 7 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Atypical antipsychotic |
Approved | 5 Apr 2027Phase 3 trial completes | |||
| Next date | 5 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Irritability Associated With Autism Spectrum Disorder, Major Depressive Disorder and 5 more | ||||
| Open drug page | |||||
Ecopipam Hydrochloridenot checked |
— |
Phase 3 | Feb 2028Phase 3 trial completes | ||
| Next date | Feb 2028 · Phase 3 trial completes | ||||
| Also tested for | Tourette Syndrome | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 2 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026